REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharminal Ilac San. Ve Tic. Ltd. Sti. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pharminal Ilac Sanayi Ve Ticaret Limited Sirketi Profile Updated: October 02, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Pharminal Ilac San. Ve Tic. Ltd. Sti. is an enterprise in Turkiye, with the main office in Ankara. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It currently has a total number of 45 (2024) employees. From the latest financial highlights, Pharminal Ilac San. Ve Tic. Ltd. Sti. reported a net sales revenue increase of 80.63% in 2022. A growth of 39.31% was recorded in its total assets. Pharminal Ilac San. Ve Tic. Ltd. Sti.’s net profit margin increased by 1.15% in 2022.

Headquarters
No:9 Yeni Bati Mahallesi 2382 Sokak Yenimahalle
Ankara; Central Anatolia; Postal Code: 06370

Contact Details: Purchase the Pharminal Ilac San. Ve Tic. Ltd. Sti. report to view the information.

Website: http://www.pharminalilac.com

Basic Information
Total Employees:
Purchase the Pharminal Ilac San. Ve Tic. Ltd. Sti. report to view the information.
Outstanding Shares:
Purchase the Pharminal Ilac San. Ve Tic. Ltd. Sti. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Pharminal Ilac San. Ve Tic. Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
80.63%
Total operating revenue
80.63%
Operating profit (EBIT)
97.4%
Net Profit (Loss) for the Period
225.01%
Total assets
39.31%
Total equity
30.77%
Operating Profit Margin (ROS)
0.17%
Net Profit Margin
1.15%
Return on Equity (ROE)
30.33%
Debt to Equity Ratio
-6.25%
Quick Ratio
0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?